Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
4.900
+0.050 (1.03%)
Nov 22, 2024, 4:00 PM EST - Market closed
Pluri Revenue
Pluri had revenue of $326.00K in the quarter ending September 30, 2024, with 503.70% growth. This brings the company's revenue in the last twelve months to $598.00K, up 135.43% year-over-year. In the fiscal year ending June 30, 2024, Pluri had annual revenue of $326.00K with 13.59% growth.
Revenue (ttm)
$598.00K
Revenue Growth
+135.43%
P/S Ratio
43.54
Revenue / Employee
$5,068
Employees
118
Market Cap
27.24M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nortech Systems | 135.57M |
ImmuCell | 23.84M |
Surrozen | 10.00M |
DURECT | 8.59M |
Marker Therapeutics | 5.40M |
Daré Bioscience | 1.88M |
SAB Biotherapeutics | 1.51M |
OneMedNet | 1.02M |
PLUR News
- 10 days ago - Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 11 days ago - BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing - PRNewsWire
- 4 months ago - Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates - GlobeNewsWire
- 5 months ago - Pluri: Biotech Play With Several Opportunities Across Different Sectors - Seeking Alpha
- 5 months ago - Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges - GlobeNewsWire
- 6 months ago - U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract - GlobeNewsWire
- 6 months ago - Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale - GlobeNewsWire
- 7 months ago - Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment - GlobeNewsWire